Tamoxifen use reduces the risk of osteoporotic fractures in women with breast cancer in Asia: a nationwide population-based cohort study

PURPOSE: Bone mineral density changes with tamoxifen treatment have been reported in pre- and post-menopausal women with breast cancer. However, there remains controversy as to whether tamoxifen significantly reduces fracture rates in different age groups. Breast cancer occurs at 10-20 years younger...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzeng, Huey-En, Muo, Chih-Hsin, Chen, Hsien-Te, Hwang, Wen-Li, Hsu, Horng-Chang, Tsai, Chun-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438570/
https://www.ncbi.nlm.nih.gov/pubmed/25989902
http://dx.doi.org/10.1186/s12891-015-0580-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438570/
https://www.ncbi.nlm.nih.gov/pubmed/25989902
http://dx.doi.org/10.1186/s12891-015-0580-8

Ejemplares similares